Page last updated: 2024-09-03

formylmethionyl-leucyl-phenylalanine methyl ester and Liver Cirrhosis, Alcoholic

formylmethionyl-leucyl-phenylalanine methyl ester has been researched along with Liver Cirrhosis, Alcoholic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Djerdjouri, B; El-Benna, J; Elkrief, L; Hadjoudj, S; Makhezer, N; Moreau, R; PĂ©rianin, A; Rolas, L1

Other Studies

1 other study(ies) available for formylmethionyl-leucyl-phenylalanine methyl ester and Liver Cirrhosis, Alcoholic

ArticleYear
Inhibition of mammalian target of rapamycin aggravates the respiratory burst defect of neutrophils from decompensated patients with cirrhosis.
    Hepatology (Baltimore, Md.), 2013, Volume: 57, Issue:3

    Topics: Antibiotics, Antineoplastic; Cytosol; Drug Interactions; Escherichia coli Infections; Female; HL-60 Cells; Humans; Liver Cirrhosis, Alcoholic; Male; MAP Kinase Signaling System; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophils; p38 Mitogen-Activated Protein Kinases; Phagocytosis; Phosphorylation; Respiratory Burst; Sirolimus; TOR Serine-Threonine Kinases

2013